AHB-171 treatment for chronic hepatitis B
Treatments studied
Part of Digestive system, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study tests whether a new drug called AHB-171 can help treat chronic hepatitis B (a long-term liver infection). You would receive the drug by injection under your skin and be monitored to see if it helps reduce the hepatitis B virus and improves liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic hepatitis B that has been confirmed for at least 6 months
- You are between 18 and 65 years old and in generally good health
- Your liver disease is stable—no signs of advanced scarring, cirrhosis, or liver cancer
- You have not had certain other serious infections, liver diseases, or organ transplants
- You agree to use effective birth control during the study and avoid certain other medications or vaccines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This study tests a new injection called AHB-137 in people with chronic hepatitis B who have never received antiviral treatment. The goal is to see if it can help reduce the hepatitis B virus in the body and improve liver health.
This study tests a new injection called AHB-137 combined with other hepatitis B drugs. It aims to see if the combination can better control the virus in people with chronic hepatitis B who are already on antiviral pills.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This trial tests a new investigational drug called AHB-171 for people with chronic hepatitis B who are already stable on standard antiviral therapy. It aims to see if the drug is safe and may help control the virus better.
This study tests a new experimental drug called AHB-171 in people with chronic hepatitis B infection. The trial aims to see how safe the drug is and how well it works to help control the virus.
Hear when a new Hepatitis B, Chronic (CHB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.